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REVIEW CURRENTOPINION Dynamic models of viral replication and latencywww.co-hivandaids.coma,b,c a b,cPejman Mohammadi , Angela Ciuffi , and Niko BeerenwinkelPurpose of review
HIV targets primary CD4þ T cells. The virus depends on the physiological state of its target cells for efficient
replication, and, in turn, viral infection perturbs the cellular state significantly. Identifying the virus–host
interactions that drive these dynamic changes is important for a better understanding of viral pathogenesis
and persistence. The present review focuses on experimental and computational approaches to study the
dynamics of viral replication and latency.
Recent findings
It was recently shown that only a fraction of the inducible latently infected reservoirs are successfully
induced upon stimulation in ex-vivo models while additional rounds of stimulation make allowance for
reactivation of more latently infected cells. This highlights the potential role of treatment duration and timing
as important factors for successful reactivation of latently infected cells. The dynamics of HIV productive
infection and latency have been investigated using transcriptome and proteome data. The cellular
activation state has shown to be a major determinant of viral reactivation success. Mathematical models of
latency have been used to explore the dynamics of the latent viral reservoir decay.
Summary
Timing is an important component of biological interactions. Temporal analyses covering aspects of viral
life cycle are essential for gathering a comprehensive picture of HIV interaction with the host cell and
untangling the complexity of latency. Understanding the dynamic changes tipping the balance between
success and failure of HIV particle production might be key to eradicate the viral reservoir.
Keywords
cure, dynamic model, HIV, latency, transcriptome dynamicsaInstitute of Microbiology, University Hospital of Lausanne, University of
Lausanne, Lausanne, bDepartment of Biosystems Science and Engin-
eering, ETH Zurich and cSwiss Institute of Bioinformatics, Basel,
Switzerland
Correspondence to Angela Ciuffi, Institute of Microbiology, CHUV, 1011
Lausanne, Switzerland. Tel: +41 213144099; e-mail: angela.ciuffi@
chuv.ch
Curr Opin HIV AIDS 2015, 10:90–95
DOI:10.1097/COH.0000000000000136
This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivatives 4.0 License, where
it is permissible to download and share the work provided it is properly
cited. The work cannot be changed in any way or used commercially.INTRODUCTION
Current antiretroviral therapy (ART) is successful in
inhibiting viral replication (defined as undetectable
plasma viremia using standard assays, i.e., below
20–50 copies/ml) and transmission, but fails to
completely eliminate HIV. Indeed, the presence of
continuous low-level viremia (detectable using
ultrasensitive assays) or occasional viral blips under
ART and the observation that viremia rebounds
rapidly upon ART cessation indicate the existence
of viral reservoirs [1]. Viral reservoirs are established
early, during the first 3 days upon viral exposure
[2
&
,3,4]. Their exact nature has yet to be completely
understood, but includes anatomical sanctuaries
and cellular reservoirs. Although still controversial,
anatomical sanctuaries are described as sites with
incomplete ART penetration, where infected cells
may reside with continuous low levels of viral
replication and may include lymph nodes, gut-
associated lymphoid tissue, and the central nervous
system [5–8]. Cellular reservoirs are described as
being latently infected cells, i.e. infected cells that
do not produce replication-competent virions and
include mostly long-lived resting memory CD4þ Tcells [8–10]. The current dogma is that the major
HIV reservoir originates from activated CD4þ T cells
that have been infected and survive while reverting
to a resting state, thereby becoming a memory cell.
Because of the intrinsic physiology of resting mem-
ory cells, no infectious virions are produced, hence
the concept of latent infection. Bursts of viral pro-
duction, however, may occur from time to time as
manifested by viral blips. Although the cellular
mechanisms contributing to sudden induction of
viral blips in otherwise aviremic individuals are yetVolume 10  Number 2  March 2015
KEY POINTS
 Viral processes (replication, latency, and reactivation
from latency) are dependent on the cellular
composition – and thus on the cell type/subset, cell
state (resting or dividing), and nature of latency
(transcriptional or posttranscriptional block) – and on
the extracellular environment (type of stimuli and
exposure time) (Fig. 1).
 Time series experiments are useful in resolving the
causes and effects of virus–host interactions.
 Dynamic models give insight into time-dependent
changes that take place in the host cell environment
and thus into viral reproductive success.
Dynamic models of viral replication and latency Mohammadi et al.poorly defined, viral production and viral latency
appear to be intertwined and closely linked to cell
physiology and activation (Fig. 1).
Viral infection and replication are successful in
activated CD4þ T cells, while poorly efficient in
resting CD4þ T cells (Fig. 1a). The timing of the
infection event might impact on the type of post-
integration block in the latent cell (Fig. 1a and b).
Therefore, viral reactivation from latency might
need different types of stimuli to reverse several
types of latency [11
&
,12
&&
]. Furthermore, different
types of latent cells may need to be exposed for
different time lengths to successfully trigger a pro-
ductive infection (Fig. 1c). Finally, the efficiency of
viral production or the type of latency can impact
the kinetics of cell death and thus the elimination of
the reservoir of latently infected cells (Fig. 1d). An
additional layer of complexity may reside in the
possibility of having multiple blocks within the
same cells, which would require multiple stimuli
with specific time schedules of administration to be
reactivated. In conclusion, the dynamics of estab-
lishment of a successful infection and production,
including the type of cell stimulation, the time
required for stimulation, the stimulated subset of
cells, and the type of block, might be key for under-
standing viral latency and for the development of
appropriate strategies aiming at purging viral reser-
voirs and eradicating HIV.THE OBSTACLE OF THE INDUCIBLE
RESERVOIR
Initial studies measuring the size of the latent viral
reservoir aimed at quantifying the number of circu-
lating latently infected cells in the plasma. For this
purpose, the gold standard is the viral outgrowth
assay: resting CD4þ T cells are collected from
patients, serially diluted, and activated with1746-630X Copyright  2015 Wolters Kluwer Health, Inc. All rights resephytohemagglutin/interleukin 2 (IL-2) and 10
excess of irradiated peripheral blood mononuclear
cells.CD4þ lymphoblasts (fromahealthyHIVdonor)
are added the next day (day 2) and at days 7 and 14,
and viral production ismeasured by p24 ELISA at day
21 [13
&
,14]. Using this assay, 1 of 106 cells was
reported to produce infectious particles and thus
consideredtobe latently infected [13
&
]. Interestingly,
using PCR to detect proviral DNA, 1000 of 106 cells
were shown to be infected by HIV [13
&
]. Recent
findings [15] showed that 88.3% of infected cells
carry defective copies of HIV DNA and are thus not
able to produce infectious and replication-compe-
tent viral particles. The remaining infected cells
(11.7%) carry intact viral DNA and are potentially
able to be induced (hence referred to as the inducible
viral reservoir) and produce infectious particles,
suggesting that the size of the viral reservoir is on
the order of 60 latently infected per 1 million cells.
Only a fraction of these inducible cells, however, is
efficiently stimulated in vitro using the standard viral
outgrowth assay. An additional round of cell stimu-
lation allows inducing viral production from
additional cells, but not all, suggesting that acti-
vation conditions, time, and stochasticity play a role
in successful induction of viral production from
latently infected cells [15]. Similar observations were
reported upon stimulation of resting CD4þ T cells
using CD3/CD28 antibodies for 7 days in the pres-
ence of efavirenz to block viral replication and
measuring cell-associated and supernatant viral
RNA by reverse transcription followed by quantitat-
ive polymerase chain reaction (RT-qPCR) [16
&&
,17
&&
].
Under these conditions, cell-associated viral RNA
was detected in 7.5% of latently infected cells, while
only 1.5% of cells were able to be induced and pro-
duce viral particles (as detected by viral RNA in the
supernatant), confirmingpreviousobservations [15].
Of note, spontaneous virion production in the
absence of activation was detected in 0.041% of
latently infected cells.
These recent findings highlight the current gap
between the experimentally induced reservoir and
the total inducible reservoir, and demonstrate that
the type and time of stimulation affect the size of the
induced reservoir. This underlines the need for new
experiments that investigate the stimulation
dynamics leading to maximal viral reactivation, so
that the total inducible reservoir is de facto induced.DYNAMIC MODELS
Numerous modeling approaches have been applied
to facilitate understanding of various aspects of HIV
biology [18–20]. Here, we consider two major
categories of modeling approaches applied to therved. www.co-hivandaids.com 91
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FIGURE 1. The possible relationship between cell physiology varying over time, viral production (infection success, induction
from latency), and cell death. (a) Viral production success upon infection of the host cell in vitro depends on the time after
T-cell receptor (TCR) stimulation. Numbering 1–5 reflects the continuum of different physiological states of the cell after TCR
stimulation, which associate with different infection successes, i.e. a highly successful peak of infection (phase 3) or inefficient
infection (phase 1 and 5). (b) Viral latency is characterized by the lack of successful viral production. Latency, however, is
multifactorial, including many possible blocks (crossed arrows), such as transcription, nuclear export, translation, assembly,
and release. (c) Each specific latency block may associate with one specific reactivation kinetic. Hence, exposure to TCR
stimulation (or other types of stimuli) may induce viral production (i.e., reactivate cell production from latently infected cells)
with different kinetics depending on the nature of latency. (d) Success of viral production and viral reactivation impact the
kinetics of cell death.
Genomics in HIV infectionstudy of the dynamics of viral replication and
latency: mechanistic models that incorporate
detailed biological knowledge into systems of differ-
ential equations in order to explain the dynamic
behavior of biological systems, and descriptive stat-
isticalmodels, on the basis of large datasets obtained
from genome-wide transcriptomic and proteomic
measurements that explore patterns of similarity.Mechanistic models
Mathematical analysis of HIV infection has
traditionally been performed using mechanistic
models. Early pioneering mechanistic models92 www.co-hivandaids.comprovided insight into the pathogenesis and treat-
ment of HIV infection. These models present a
bottom-up approach to mechanistically describe
complex kinetic patterns observed in HIV infection.
Prominent examples include the complex dynamics
of viremia during the course of untreated HIV infec-
tion and the multiphasic decline of viral load under
effective treatment [18]. EarlymodelsofHIVinfection
estimated the average half-life of productively HIV-
infected cells to be approximately 1 day. A recent
study by Petravic et al. suggests that this average life
span poorly represents reality as individual infected
cells may die within a few hours to a few days. The
authors [21] observed that the rate of infected cellVolume 10  Number 2  March 2015
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with viral protein production. This observation may
impact the so-called ‘shock andkill’ strategy that aims
at reactivating viral protein expression in latently
infected cells, thereby mediating virus-induced cyto-
toxicity to kill the infected cells [22–25].
Mechanistic models have previously been devel-
oped to provide insight into the long-term dynamics
of viral latency, including degradation of the virus,
viral blips in virologically suppressed patients, reac-
tivation of quiescent infection, and time needed to
eliminate HIV under ART [19]. Immonen and Leitner
used a joint phylogenetic and differential equation
approach to model the evolutionary divergence of
the virus taken from plasma and the latently infected
cells from 26 patients. They [26] observed an over-
dispersion of evolutionary divergence relative to the
molecular clock model, suggesting that a major frac-
tion of infected cells have experienced periods of
latency at some point in the past. The stability of
the latent reservoir and the emergence of viral blips
could be explained by stochastic expression of HIV
[27,28
&
]. Hill et al. [28
&
] used a stochastic model to
describe viral rebound after ART interruption and to
define a quantitative goal for latency reactivation
approaches. The authors conclude that a 10000-fold
decrease in the latent reservoir may be necessary to
reach permanent viral remission in half of all indi-
viduals. Petravic et al. [29] devised a mathematical
model to study the efficacy of antilatency drugs
under different strategies and suggested that antila-
tency treatment should be administered early upon
initiation of ART to achieve optimal outcomes. A
recent study by Althaus et al. used longitudinal data
from five chronically infected HIV patients to
model the dynamics of different types of HIV-
infected cells defined by the splicing patterns
of the viral transcripts. In line with the study
of Petravic et al., their model suggests that the
reservoir is smaller during acute infection; thus,
eradication strategies should be started early on
in combination with ART [30].Statistical models
New transcriptomics and proteomics technologies
have enabled the collection of large-scale snapshots
of the cellular state that can provide a holistic view of
the cellular changes occurring upon viral infection at
the cell population level. Repeated high-throughput
measurements carried out in longitudinal exper-
iments make allowance for a top-down analysis of
thedynamicsof thecell.The informationprovidedby
suchtimeseriesexperiments facilitatesdistinguishing
causes and consequences observed upon viral infec-
tion, viral latency, and reactivation from latency.1746-630X Copyright  2015 Wolters Kluwer Health, Inc. All rights resePermissive T-cell lines have been used to investigate
transcriptional reprogramming of the host cell
[31–34]. Mohammadi et al. [34] analyzed the joint
virus–host transcriptome upon HIV infection with
high temporal resolution over a 24hperiod. A total of
73% of the expressed genes in the host cells were
found to be regulated in concordance with the major
viral replication steps, namely, reverse transcription,
integration, and a late phase that spans from trans-
cription to the release of new viral particles. The
longitudinal design of the experiment and the math-
ematical analysis of the paired measurements of the
viral life cycle intermediates and host transcriptome
showed that the early regulated genes were likely due
to response to the incoming virus. Mohammadi et al.
observed a massive early downregulation probably
reflecting a host cell response to viral presence. In
contrast, late regulated genes are more likely to be
regulated by newly produced viral proteins. These
findings are consistent with a recent study that inves-
tigated phosphorylation changes uponHIV exposure
[35
&
]. Using infection with X4-tropic virus in primary
resting CD4þ T cells, the authors identified rapid
changes of 239phosphorylation sites from175 genes,
someas early as1minafter exposure thatmayprepare
the cell for successful viral replication. This finding is
also in agreement with another proteomic study that
found host-induced early posttranslational modifi-
cations of histones in response to the HIV infection
occurring as early as 4h after exposure [36]. Similar
patterns of early regulation were observed in micro-
RNAs (miRNAs) [32]. Peng et al. [37] performed a joint
analysis of transcriptome by mRNA sequencing and
total RNA sequencing at 12 and 24h after infection in
a T-cell model. Their results suggest that a total RNA
sequencing assay, quantifying also nascent and non-
maturetranscripts,maydetect transcriptomechanges
earlier than mRNA sequencing.
Mohammadi et al. [12
&&
] investigated the tran-
scriptome of the infected cells establishing and exit-
ing latency. Resting CD4þ T cells were activated,
infected with an HIV-based vector, and allowed to
revert to a resting cellular state during 10 weeks
using a feeder cell layer. Cells were then stimulated
with various latency reactivating agents or with
CD3/CD28/IL-2 for 8 or 24h. This study demon-
strated stable persistence of viral transcripts in
latently infected cells over time, suggesting that
in this system, the latently infected cells failed to
produce viral particles because of posttranscrip-
tional rather than transcriptional blocks. The
analysis highlighted the biological state of the host
cell, i.e. resting versus activated, as a major driver of
differences between latent and productive infection
[12
&&
,38
&
]. Additional time series analyses focusing
on the reactivation of cells will help to identify therved. www.co-hivandaids.com 93
Genomics in HIV infectionkey determinants driving the cascade of regulatory
events leading to successful induction of viral pro-
duction in latently infected cells.CONCLUSION
Mathematical models have proven beneficial to
make long-term predictions about the viral and
cellular behaviors. They help defining strategies
aiming at viral eradication. These predictions
include estimation of the ART duration required
to eliminate the viral reservoir and the critical size
of the viral reservoir for sustained viral remission.
Large-scale temporal analyses have been used to
describe HIV replication at the cell population level.
In the future, integrative analyses involving collec-
tions of paired transcriptomic and proteomic datasets
should produce amore comprehensive picture of the
sequence of events occurring upon cell exposure to
the virus, latency establishment, and reactivation
from latency. These analysesmay benefit from recent
technological developments, such as single-cell tech-
nologies to measure the state of multiple individual
cells. Single-cell approaches should allow a better
assessment of stochastic expression of latent HIV,
the impact of latency reactivating agents, and the
optimal conditions (treatment type and exposure
time) required to induce viral production fromdiffer-
ent types of latently infected cells. Repeated analysis
of the transcriptome or proteome of a single cell over
time is currently not feasible. Combination of popu-
lation and single-cell analysis over time, however,
might help identifying and dissecting the multiple
types of latent cells.
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